Persistent Fetal Circulation Syndrome: Clinical Trials

8 trials for Persistent Fetal Circulation Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 withdrawn, 2 completed, 2 terminated, 1 recruiting. 8 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Withdrawn 3, Completed 2, Terminated 2, Recruiting 1
Phase 13Completed 1, Recruiting 1, Withdrawn 1

Follow Persistent Fetal Circulation Syndrome: new trials by email Literature Review of Persistent Fetal Circulation Syndrome trials Research Report on Persistent Fetal Circulation Syndrome

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn
Magnesium sulfate, Sildenafil Citrate, Isotonic saline - Persistent Pulmonary Hypertension of Newborn
Phase 1 / Phase 2RecruitingSohag University402021-06-022024-11-27
Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn
Nebulized Magnesium Sulfate, Intravenous Magnesium Sulfate - Persistent Fetal Circulation, Persistent Pulmonary Hypertension of the Newborn
Phase 1 / Phase 2CompletedSohag University282017-11-012020-08-18
Milrinone in Congenital Diaphragmatic Hernia
Milrinone, Placebo (5% Dextrose) - Congenital Diaphragmatic Hernia, Persistent Pulmonary Hypertension of the Newborn
Phase 2CompletedNICHD Neonatal Research Network662017-10-242025-11-06
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
IV Remodulin, Placebo - Persistent Pulmonary Hypertension of the Newborn
Phase 2TerminatedUnited Therapeutics422015-07-292024-03-05
IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn
Sildenafil - Persistent Pulmonary Hypertension of the Newborn
Phase 2WithdrawnPfizer's Upjohn has merged with Mylan to form Viatris Inc.2012-03-012021-02-02
Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)
sildanefil - PPHN, Persistent Pulmonary Hypertension of the Newborn
Phase 2TerminatedPfizer's Upjohn has merged with Mylan to form Viatris Inc.42010-12-012021-02-01
Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
Iloprost, Placebo - Pulmonary Hypertension, Neonatal Hypoxic Respiratory Failure
Phase 1 / Phase 2WithdrawnSeattle Children's Hospital2009-09-012015-01-19
Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure
Inhaled Prostaglandin E1 - Infant, Newborn, Respiratory Insufficiency
Phase 2WithdrawnNICHD Neonatal Research Network2008-05-012019-03-22

Narrower conditions

Hypertension, Pulmonary (2)  ·  Hypoxia (2)  ·  Respiratory Insufficiency (2)  ·  Heart Defects, Congenital (1)  ·  Hernias, Diaphragmatic, Congenital (1)  ·  Meconium Aspiration Syndrome (1)  ·  Respiratory Distress Syndrome (1)  ·  Respiratory Distress Syndrome, Newborn (1)  ·  Streptococcal Infections (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (8)  ·  Infant, Newborn, Diseases (8)  ·  Lung Diseases (8)  ·  Respiratory Tract Diseases (8)  ·  Hypertension, Pulmonary (6)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Respiration Disorders (3)  ·  Cardiovascular Diseases (2)  ·  Congenital Abnormalities (2)  ·  Hypertension (2)  ·  Signs and Symptoms (2)  ·  Signs and Symptoms, Respiratory (2)  ·  Vascular Diseases (2)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)

Interventions

Sildenafil Citrate (2)  ·  Alprostadil (1)  ·  Glucose (1)  ·  Iloprost (1)  ·  Magnesium Sulfate (1)  ·  Milrinone (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  treprostinil (1)

Sponsors

NICHD Neonatal Research Network (2)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (2)  ·  Sohag University (2)  ·  Seattle Children's Hospital (1)  ·  United Therapeutics (1)

Countries

United States (3)  ·  Egypt (2)  ·  United Kingdom (1)

Top investigators

Elsayed Abdelkreem, MD, PhD (2)  ·  Delphine Yung, MD (1)  ·  Edward F. Bell, MD (1)  ·  Krisa P. Van Meurs, MD (1)  ·  Kristi L. Watterberg, MD (1)  ·  Michele C. Walsh, MD MS (1)  ·  Pablo J. Sanchez, MD (1)  ·  Roger G. Faix, MD (1)  ·  Ronald N. Goldberg, MD (1)  ·  Satyan Lakshminrusimha, M.D. (1)  ·  Seetha Shankaran, MD (1)  ·  Waldemar A. Carlo, MD (1)

Results publications

PMID 25496504, PMID 29209510, PMID 33415555

NIH funding

U10HD036790 (2), U10HD021364 (1), U10HD021385 (1), U10HD027880 (1), U10HD034216 (1), U10HD040492 (1), U10HD040689 (1), U10HD053089 (1), U10HD053109 (1), U10HD053119 (1), U10HD053124 (1), UG1HD021364 (1), UG1HD027851 (1), UG1HD027853 (1), UG1HD027880 (1)